Literature DB >> 17609278

Defect of human immunodeficiency virus type 2 Gag assembly in Saccharomyces cerevisiae.

Yuko Morikawa1, Toshiyuki Goto, Daisuke Yasuoka, Fumitaka Momose, Tetsuro Matano.   

Abstract

We have previously shown that the expression of human immunodeficiency virus type 1 (HIV-1) Gag protein in Saccharomyces cerevisiae spheroplasts produces Gag virus-like particles (VLPs) at the plasma membrane, indicating that yeast has all the host factors necessary for HIV-1 Gag assembly. Here we expand the study by using diverse primate lentiviral Gags and show that yeast does not support the production of HIV-2 or simian immunodeficiency virus SIVmac Gag VLPs but allows the production of SIVagm and SIVmnd Gag VLPs. Particle budding was observed at the surfaces of cells expressing SIVagm and SIVmnd Gags, but cells expressing HIV-2 and SIVmac Gags showed only membrane-ruffling structures, although they were accompanied with electron-dense submembrane layers, suggesting arrest at an early stage of particle budding. Comparison of HIV-1 and HIV-2 Gag expression revealed broadly equivalent levels of intracellular Gag expression and Gag N-terminal myristoylation in yeast. Both Gags showed the same membrane-binding ability and were incorporated into lipid raft fractions at a physiological concentration of salt. HIV-2 Gag, however, failed to form a high-order multimer and easily dissociated from the membrane, phenomena which were not observed in higher eukaryotic cells. A series of chimeric Gags between HIV-1 and HIV-2 and Gag mutants with amino acid substitutions revealed that a defined region in helix 2 of HIV-2 MA (located on the membrane-binding surface of MA) affects higher-order Gag assembly and particle production in yeast. Together, these data suggest that yeast may lack a host factor(s) for HIV-2 and SIVmac Gag assembly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609278      PMCID: PMC2045428          DOI: 10.1128/JVI.00027-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Plasma membrane rafts play a critical role in HIV-1 assembly and release.

Authors:  A Ono; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding.

Authors:  Bettina Strack; Arianna Calistri; Stewart Craig; Elena Popova; Heinrich G Göttlinger
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

3.  Pep12p is a multifunctional yeast syntaxin that controls entry of biosynthetic, endocytic and retrograde traffic into the prevacuolar compartment.

Authors:  S R Gerrard; B P Levi; T H Stevens
Journal:  Traffic       Date:  2000-03       Impact factor: 6.215

4.  Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells.

Authors:  D Braaten; J Luban
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

5.  Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag).

Authors:  L VerPlank; F Bouamr; T J LaGrassa; B Agresta; A Kikonyogo; J Leis; C A Carter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

6.  Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors.

Authors:  Greg J Towers; Theodora Hatziioannou; Simone Cowan; Stephen P Goff; Jeremy Luban; Paul D Bieniasz
Journal:  Nat Med       Date:  2003-08-03       Impact factor: 53.440

Review 7.  Restriction factors: a defense against retroviral infection.

Authors:  Paul D Bieniasz
Journal:  Trends Microbiol       Date:  2003-06       Impact factor: 17.079

8.  HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae.

Authors:  Sayuri Sakuragi; Toshiyuki Goto; Kouichi Sano; Yuko Morikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

9.  Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast.

Authors:  M Bagnat; S Keränen; A Shevchenko; A Shevchenko; K Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

10.  The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag.

Authors:  S Sandefur; V Varthakavi; P Spearman
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

View more
  8 in total

1.  Access of HIV-2 to CD169-dependent dendritic cell-mediated trans infection pathway is attenuated.

Authors:  Suzanne D G Kijewski; Hisashi Akiyama; Amin Feizpour; Caitlin M Miller; Nora-Guadalupe P Ramirez; Björn M Reinhard; Suryaram Gummuluru
Journal:  Virology       Date:  2016-08-11       Impact factor: 3.616

2.  Human Immunodeficiency Virus Type 2 (HIV-2) Gag Is Trafficked in an AP-3 and AP-5 Dependent Manner.

Authors:  Justine E Alford; Michela Marongiu; Gemma L Watkins; Emma C Anderson
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

3.  Mechanistic Studies and Modeling Reveal the Origin of Differential Inhibition of Gag Polymorphic Viruses by HIV-1 Maturation Inhibitors.

Authors:  Zeyu Lin; Joseph Cantone; Hao Lu; Beata Nowicka-Sans; Tricia Protack; Tian Yuan; Hong Yang; Zheng Liu; Dieter Drexler; Alicia Regueiro-Ren; Nicholas A Meanwell; Mark Cockett; Mark Krystal; Max Lataillade; Ira B Dicker
Journal:  PLoS Pathog       Date:  2016-11-28       Impact factor: 6.823

4.  Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting.

Authors:  Jamil S Saad; Sherimay D Ablan; Ruba H Ghanam; Andrew Kim; Kalola Andrews; Kunio Nagashima; Ferri Soheilian; Eric O Freed; Michael F Summers
Journal:  J Mol Biol       Date:  2008-07-16       Impact factor: 5.469

5.  Trans-packaging of human immunodeficiency virus type 1 genome into Gag virus-like particles in Saccharomyces cerevisiae.

Authors:  Naoki Tomo; Toshiyuki Goto; Yuko Morikawa
Journal:  Microb Cell Fact       Date:  2013-03-26       Impact factor: 5.328

6.  Biological and biochemical characterization of HIV-1 Gag/dgp41 virus-like particles expressed in Nicotiana benthamiana.

Authors:  Sarah A Kessans; Mark D Linhart; Nobuyuki Matoba; Tsafrir Mor
Journal:  Plant Biotechnol J       Date:  2013-03-19       Impact factor: 9.803

7.  Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage.

Authors:  Beata Nowicka-Sans; Tricia Protack; Zeyu Lin; Zhufang Li; Sharon Zhang; Yongnian Sun; Himadri Samanta; Brian Terry; Zheng Liu; Yan Chen; Ny Sin; Sing-Yuen Sit; Jacob J Swidorski; Jie Chen; Brian L Venables; Matthew Healy; Nicholas A Meanwell; Mark Cockett; Umesh Hanumegowda; Alicia Regueiro-Ren; Mark Krystal; Ira B Dicker
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

Review 8.  Construction and characterization of virus-like particles: a review.

Authors:  Andris Zeltins
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.